Arriving in the field of obesity therapy, retatrutide presents a unique method. Different from many current medications, retatrutide functions as a dual agonist, at once affecting both GLP-like peptide-1 (GLP-1) and https://haseebrihc166855.anchor-blog.com/19042072/this-novel-retatrutide-the-glp-gip-receptor-agonist